We would love to hear your thoughts about our site and services, please take our survey here.
ah spotted - that's disappointing
E.8.9 Initial estimate of the duration of the trial
E.8.9.1 In the Member State concerned years 0
E.8.9.1 In the Member State concerned months 6
E.8.9.1 In the Member State concerned days 0
E.8.9.2 In all countries concerned by the trial years 1
nearly killed me, 60% wipe out in 2 weeks, CHRIST ALIVE!
unfortunately Doc, we already know we are not getting the more seriously ill patients on our P2 ACTIV-2, the panellist told us that in the interview.
'Interferon-Beta is being used on mild outpatient cases, the seriously ill patients are being reserved for the injected or infused agents'
hTTps://www.facebook.com/kuhospital/videos/1116924078826762/
I'm not convinced a British product we will be included in the EU priority list, especially given their frustration with AZ on the vaccine production side and Brexit.
They would be more likely to take up the French interferon trial than ours. IMO
Look at the same websites data set presented in a different format Fruitsneg and you get an better visual of the current situation in SA.
Very low COVID numbers, thus very low trial patient numbers for clinical trials.
https://www.statista.com/statistics/1107993/coronavirus-cases-in-south-africa/
'I think the number recruited is closer to 90 in the UK now but will be really slow as hospitalisation is very slow.
I expect they may apply to change the sleeve size.'
@ Deal3r, are you able to provide any reference to this patient recruitment figure? any assistance would ben appreciated if so.
This is silly, Scinv has provided the link proving Synairgen was included in this publication last August 2020
Open your browser and enter the following link in full (It will show you the original publication naming SNG and shows publication date Aug 20):
http://web.archive.org/web/20200831023318/https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html
Any discussions stating anything to the contrary are incorrect - FACT!